Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Magnanimous Trade & Finance Ltd

MAGANTR
BSE
5.64
Company Overview
Alert
Watchlist
Note

Magnanimous Trade & Finance Ltd

MAGANTR
BSE
5.64
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
13Cr
Close
Close Price
5.64
Industry
Industry
Finance
PE
Price To Earnings
PS
Price To Sales
4.47
Revenue
Revenue
3Cr
Rev Gr TTM
Revenue Growth TTM
-70.46%
PAT Gr TTM
PAT Growth TTM
-105.32%
Peer Comparison
How does MAGANTR stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
MAGANTR
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
000000091011
Growth YoY
Revenue Growth YoY%
0.0380.0450.0100.01,125.0-41.736.48,720.0136.7128.6126.7-91.8
Expenses
ExpensesCr
0000141021000
Operating Profit
Operating ProfitCr
0000-14-1070010
OPM
OPM%
-100.045.836.4-20.0-2,812.2-450.06.778.35.240.682.350.0
Other Income
Other IncomeCr
0000360000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000022-1070010
Tax
TaxCr
000040002000
PAT
PATCr
000018-107-2000
Growth YoY
PAT Growth YoY%
-550.01,000.0-82.3300.020,200.0-777.8-100.035,550.0-110.2144.3-100.1
NPM
NPM%
-225.037.540.920.03,691.8-435.70.080.8-158.684.439.7-1.4
EPS
EPS
-0.90.00.90.2190.0-6.40.074.9-19.32.92.8-0.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2025TTM
Revenue
RevenueCr
0000001010103
Growth
Revenue Growth%
-90.9-100.0-45.751.1788.7-75.967.8-67.1-72.4
Expenses
ExpensesCr
000000100042
Operating Profit
Operating ProfitCr
000000100061
OPM
OPM%
-133.3-1,733.1-117.9-252.8-116.738.5-9.319.0-79.661.038.5
Other Income
Other IncomeCr
000100000100
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000100071
Tax
TaxCr
000000000022
PAT
PATCr
00000010004-1
Growth
PAT Growth%
-109.4-305.1622.3-69.7-37.5915.9-93.9395.6154.0-134.9
NPM
NPM%
77.3-79.8147.982.634.239.19.929.4226.536.0-45.5
EPS
EPS
1.6-0.1-0.63.00.90.65.80.30.00.0-13.8

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
111111111111
Reserves
ReservesCr
66677777783131
Current Liabilities
Current LiabilitiesCr
0000000010
Non Current Liabilities
Non Current LiabilitiesCr
0000000000
Total Liabilities
Total LiabilitiesCr
87788888993233
Current Assets
Current AssetsCr
5555522221
Non Current Assets
Non Current AssetsCr
3332267787
Total Assets
Total AssetsCr
87788888993233

Cash Flow

Consolidated
Standalone
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2025
Operating Cash Flow
Operating Cash FlowCr
-100-10000-1-16
Investing Cash Flow
Investing Cash FlowCr
100100001-1
Financing Cash Flow
Financing Cash FlowCr
0000000000
Net Cash Flow
Net Cash FlowCr
000000000-17
Free Cash Flow
Free Cash FlowCr
-100-10000-2
CFO To PAT
CFO To PAT%
-605.41,001.0571.9-197.3-777.6-54.4-206.5-223.4-241.7-425.1
CFO To EBITDA
CFO To EBITDA%
351.046.195.1247.7227.6-55.1221.1-344.5687.7-250.6

Ratios

Consolidated
Standalone
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
0000000000
Price To Earnings
Price To Earnings
0.00.00.00.00.00.00.00.00.00.0
Price To Sales
Price To Sales
0.00.00.00.00.00.00.00.00.00.0
Price To Book
Price To Book
0.00.00.00.00.00.00.00.00.00.0
EV To EBITDA
EV To EBITDA
0.20.10.10.20.00.00.06.6-0.80.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.0100.0100.0100.0100.0100.0100.0100.0100.0
OPM
OPM%
-133.3-1,733.1-117.9-252.8-116.738.5-9.319.0-79.661.0
NPM
NPM%
77.3-79.8147.982.634.239.19.929.4226.536.0
ROCE
ROCE%
2.1-0.3-0.84.71.71.19.01.22.65.720.6
ROE
ROE%
2.0-0.2-0.83.81.10.76.80.42.04.911.8
ROA
ROA%
1.9-0.2-0.73.71.10.76.70.41.94.811.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Magnanimous Trade & Finance Limited is a **BSE-listed (Scrip Code: 512377)** Non-Banking Financial Company (**NBFC**) that is currently undergoing a transformative phase. Following a significant change in ownership and management in late **2024**, the company is pivoting toward a restructured capital base and a rationalized asset portfolio to drive future growth under new leadership. --- ### **Core Regulatory Status and Operational Framework** The company is registered with the **Reserve Bank of India (RBI)** as a **Non-Deposit Taking NBFC** (Registration No. **05.01962**). It operates within a strictly regulated environment overseen by the **RBI**, the **Ministry of Corporate Affairs (MCA)**, and **SEBI**. * **Primary Business Segment:** The company’s sole reportable segment under **Ind AS 108** is **Finance & Investment activities**. * **Financial Soundness:** As of March 31, 2025, the company reported a **Net Owned Fund of ₹31.67 crore**, which is more than **15 times** the regulatory minimum of **₹2 crore**. * **Capital Adequacy:** The company maintains a **Capital to Risk-weighted Assets Ratio (CRAR)** in excess of the mandatory **15%** requirement. * **Operational Restrictions:** The company does not engage in housing finance, is not classified as a Core Investment Company (**CIC**), and has maintained a strict policy against trading or investing in **Crypto or Virtual currencies** during the **2023-24** and **2024-25** fiscal years. --- ### **Strategic Change in Control and Management** A pivotal shift in the company’s trajectory occurred following a **Share Purchase Agreement (SPA)** dated **November 13, 2024**, leading to a change in the promoter group. * **New Leadership:** **Mr. Kurjibhai Premjibhai Rupareliya** has assumed control as the new promoter and was appointed **Managing Director** for a **5-year term** effective **September 8, 2025**. * **Acquisition Details:** The acquirer purchased **6,79,350 equity shares** (**71.40%** of voting capital) from the outgoing promoters at **₹385.00 per share**, totaling **₹26.15 crore**. * **Mandatory Open Offer:** To comply with **SEBI (SAST) Regulations**, an open offer was launched for an additional **2,47,382 shares (26.00%)** at **₹391.00 per share**. * **Ownership Concentration:** Post-transaction, the new promoter group’s holding could reach up to **97.40%**, necessitating future dilution to meet the **25% Minimum Public Shareholding (MPS)** requirement within **12 months**. --- ### **Capital Restructuring and Bonus Issue** In early **2026**, the company executed a massive capitalization of its reserves to align its paid-up capital with the actual funds employed in the business. | Metric | Details | | :--- | :--- | | **Bonus Issue Ratio** | **23:1** (23 new shares for every 1 existing share) | | **Bonus Shares Allotted** | **2,18,83,764** Fully Paid-up Equity Shares | | **Capitalization Source** | **₹21,88,37,640** from **Securities Premium** and Capital Redemption Reserve | | **Authorized Capital Expansion** | Increased from **₹2.37 Crores** to **₹23.00 Crores** | | **Post-Bonus Paid-up Capital** | Approximately **₹22.83 Crores** | --- ### **Asset Rationalization and Geographic Footprint** Under the new management, the company has aggressively moved to liquidate non-core assets and expand its physical presence across India. * **Divestment of Associates:** In **November 2024**, the company liquidated its entire **28.60%** stake (**2,87,630 shares**) in **Amber Mercantiles Limited** for **₹14.38 Lakhs**. As of March 31, 2025, the company has **no subsidiaries or associates**. * **Real Estate Liquidation:** The Board has authorized the sale of commercial properties, including offices and shops located at **Plaza Kalpana, Kanpur**, to streamline the balance sheet. * **Administrative Shift:** The company established a new **Corporate Office** in **Kolkata** (December 2024) where the primary books of account are now maintained. * **Branch Expansion:** A new branch office was approved and established in **Hyderabad, Telangana**, to broaden the company's lending and investment reach. --- ### **Financial Position and Compliance Summary** The company adheres to **Indian Accounting Standards (Ind-AS)**. Its financial health is characterized by high liquidity and a lack of legacy liabilities. | Instrument/Metric | Status/Value | | :--- | :--- | | **Listing Status** | Listed on **BSE Limited** (ID: **MAGANTR**) | | **ISIN** | **INE664N01018** | | **Statutory Auditor** | **M/s K P C M & CO** (Term: **2025–2030**) | | **Pending Litigation** | **None** (as of September 2025) | | **Contingent Liabilities** | **Zero** major reported liabilities | | **Investor Education Fund** | **No dues** pending for transfer to **IEPF** | --- ### **Risk Factors and Investment Contingencies** Investors should monitor several specific risks associated with the current transition and the regulatory environment: * **Regulatory Approvals:** The **RBI approval** for the change in management (granted **March 20, 2025**) is valid for only **one year**. Any failure to finalize the transition within this window could jeopardize the new corporate structure. * **Public Shareholding Thresholds:** Because the promoter holding may exceed **75%** following the Open Offer, the company must sell down the promoter stake to **75%** within one year to comply with **SCRR** and **SEBI (LODR)** rules. This could create downward pressure on the share price. * **Offer Execution Risks:** If the number of shares tendered in the Open Offer exceeds the **26%** limit, acceptance will be on a **proportionate basis**, meaning not all investors may be able to exit at the offer price. * **Operational Transition:** While the new management intends to continue the existing finance business, they have reserved the right to **diversify into new business lines** or pursue further **mergers and acquisitions**, which introduces execution risk associated with new ventures.